Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 4 Exercise or conversion Director acquired 1,300 shares (option exercise)
  2. 4 Planned sale CHIEF LEGAL OFFICER sold 12,500 shares at an average $39.40 ($492,461)
  3. 4 Planned sale Chief Medical Officer sold 2,220 shares at $38.93 ($86,425)
  4. 4 Planned sale CHIEF FINANCIAL OFFICER sold 12,220 shares at an average $39.91 ($487,725)
  5. 4 Planned sale Chief Medical Officer sold 2,000 shares at $40.00 ($80,000)
  6. 4 Open-market buy 10% owner bought 273,972 shares at $36.50 ($9,999,978)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale Chief Medical Officer sold 1,500 shares at $35.00 ($52,500)
  12. 4 Planned sale Director sold 10,000 shares at an average $30.64 ($306,422)
  13. 4 Planned sale Director sold 1,950 shares at $23.17 ($45,182)
  14. 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 2,035 shares (option exercise)
  19. 4 Open-market sale Director sold 1,950 shares at $23.16 ($45,162)
  20. 4 Exercise or conversion Director acquired 4,534 shares (option exercise)

Page 5 of 15 · 298 filings